Fair Value Calculator Fair Value Calculator
EN DE

Blonder Tongue Laboratories, Inc (BDRLQ) Fair Value & Analysis

Technology · US · Market cap $5.8K

BT Blonder Tongue Laboratories, Inc logo Blonder Tongue Laboratories, Inc BDRLQ · US
Price$0.0004
Fair Value$0.0004
Upside+0.0%
Quality45/100
Watch Blonder Tongue Laboratories, Inc for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range $0.0004 – $0.0004

Fair value as of: Jun 26, 2026

From 10 valuation models · updated 7 days ago

Fair value updated Jun 26, 2026 — revised from $0.3700 to $0.0004 (−99.9%) since Jun 24, 2026. Share price −75.0% over the past month.

Price vs Fair Value (12 months)

$0.2756 $0.0004 Fair Value $0.0004 Mar 2025 Jul 2026

12‑month range $0.0004 – $0.2756 · fair‑value band $0.0004 – $0.0004 · the $0.0004 price screens below the $0.0004 fair value. As of Jun 26, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Blonder Tongue Laboratories, Inc (BDRLQ) currently trades at $0.0004, while our model-based Fair Value estimate is $0.0004 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 45/100 (below-average quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, Blonder Tongue Laboratories, Inc generated revenue of $18.1M at a net margin of -16.1%. Revenue grew 32.2% year over year. Net debt stands at $8.1M. Fundamentals as of Jun 26, 2026

Key figures & financial health

Revenue (TTM) $18.1M
Revenue growth (YoY) +32.2%
Net margin -16.1%
Return on equity -134%
Free cash flow $1.0M FY2024
Operating margin 6.2%
More key figures
EPS (TTM) $-0.0900
Net debt $8.1M FY2024

Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.

About the company

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers NXG modular IP video systems, CV transcoders, CV encoders, Aircaster off-air series, and the DRAKE series. The company also provides video encoding and transcoding, analog modulators, receivers and modulators, data over cable service interface specification-cable modem termination systems, fiber optics, broadband amplifiers, test and measurement products, passives, and accessories. In addition, it provides end-of-life CableCARD solutions, secure reliable transport solutions, and local content solutions for hospitality networks. Blonder Tongue Laboratories, Inc. was founded in 1950 and is based in Old Bridge, New Jersey.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

Blonder Tongue Laboratories, Inc reported revenue of $11.2M in FY2024 versus $16.4M in FY2020, a compound −9.1%/yr. Reported net income was −$1.2M in FY2024.

Revenue −9.1%/yr
FY20 $16.4M
FY21 $15.8M
FY22 $18.1M
FY23 $13.2M
FY24 $11.2M
Net income
FY20 −$7.5M
FY21 $84.0K
FY22 −$2.9M
FY23 −$2.1M
FY24 −$1.2M

Is BDRLQ fairly valued? → Check now

Similar stocks

6 more Communication Equipment stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).

Stock Price Fair Value vs Fair Value
Cisco Systems, Inc CSCO $121.53 $43.05 -65%
Foxconn Industrial Internet Co 601138 ¥78.88 ¥18.01 -77%
Zhongji Innolight Co 300308 ¥1,382 ¥223.88 -84%
Eoptolink Technology Inc 300502 ¥748.00 ¥192.70 -74%
Nokia Oyj NOKIA 291.00 CZK 79.13 CZK -73%
Motorola Solutions, Inc MSI $392.23 $190.24 -51%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Blonder Tongue Laboratories, Inc (BDRLQ) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0004 versus a price of $0.0004 — about +0% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BDRLQ?
Our model-based fair value for Blonder Tongue Laboratories, Inc is $0.0004 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0004.
What is the quality score of BDRLQ?
Blonder Tongue Laboratories, Inc has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Blonder Tongue Laboratories, Inc (BDRLQ)?
Blonder Tongue Laboratories, Inc reported trailing-twelve-month revenue of about $18.1M (latest available figure, as of Jun 26, 2026).
What is the net profit margin of BDRLQ?
The net profit margin of Blonder Tongue Laboratories, Inc is about -16.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.